Despite the significant reduction in autoimmune disease incidence in InsB-g7 CAR Treg–treated mice, at the experimental end point of 30 weeks, we could not detect donor CD45.2+ cells in the secondary lymphoid organs (including pLN) in either diabetic or nondiabetic mice (data not shown). This evidence concerns the gene MSH5 and autoimmune disease.